Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Wise

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Virus Research|November 30, 2004
Comparison of the full-length genome sequence of avian metapneumovirus subtype C with other paramyxovirusesHumphrey C M Lwamba, Rene Alvarez, Mark G Wise, et al.
Antibiotics (Basel, Switzerland)|October 28, 2025
Trends in <i>Pseudomonas aeruginosa</i> In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024Mark G Wise, James A Karlowsky, Thales J Polis, et al.
Jac-Antimicrobial Resistance|July 8, 2026
Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024)Mark G Wise, Karri A Bauer, John S Esterly, et al.
Journal of Clinical Microbiology|May 8, 2004
Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North AmericaJanice C Pedersen, Dennis A Senne, Peter R Woolcock, et al.
Journal of Clinical Microbiology|January 13, 2004
Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samplesMark G Wise, David L Suarez, Bruce S Seal, et al.
Journal of Medical Microbiology|May 19, 2007
Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCRMark G Wise, Mimi Healy, Kristy Reece, et al.
Veterinary Microbiology|March 2, 2005
Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strainsBruce S Seal, Mark G Wise, Janice C Pedersen, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22James A Karlowsky, Mark G Wise, Meredith A Hackel, et al.
Journal of Clinical Microbiology|March 28, 2008
Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreakShu-Hua Wang, Julie E Mangino, Kurt Stevenson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 25, 2020
Multicenter evaluation of the RAPIDEC® CARBA NP assay for the detection of carbapenemase production in clinical isolates of Enterobacterales and Pseudomonas aeruginosaAllison R McMullen, Meghan A Wallace, Vincent LaBombardi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Virus Research|November 30, 2004
Comparison of the full-length genome sequence of avian metapneumovirus subtype C with other paramyxovirusesHumphrey C M Lwamba, Rene Alvarez, Mark G Wise, et al.
Antibiotics (Basel, Switzerland)|October 28, 2025
Trends in <i>Pseudomonas aeruginosa</i> In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024Mark G Wise, James A Karlowsky, Thales J Polis, et al.
Jac-Antimicrobial Resistance|July 8, 2026
Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024)Mark G Wise, Karri A Bauer, John S Esterly, et al.
Journal of Clinical Microbiology|May 8, 2004
Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North AmericaJanice C Pedersen, Dennis A Senne, Peter R Woolcock, et al.
Journal of Clinical Microbiology|January 13, 2004
Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samplesMark G Wise, David L Suarez, Bruce S Seal, et al.
Journal of Medical Microbiology|May 19, 2007
Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCRMark G Wise, Mimi Healy, Kristy Reece, et al.
Veterinary Microbiology|March 2, 2005
Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strainsBruce S Seal, Mark G Wise, Janice C Pedersen, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22James A Karlowsky, Mark G Wise, Meredith A Hackel, et al.
Journal of Clinical Microbiology|March 28, 2008
Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreakShu-Hua Wang, Julie E Mangino, Kurt Stevenson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 25, 2020
Multicenter evaluation of the RAPIDEC® CARBA NP assay for the detection of carbapenemase production in clinical isolates of Enterobacterales and Pseudomonas aeruginosaAllison R McMullen, Meghan A Wallace, Vincent LaBombardi, et al.
Pageof 4